Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Final statistical plan agreed for two pivotal Targretin trials

April 2, 2004

Axcan receives European marketing approval for Photobarr PDT

April 2, 2004

Potent syncretic antimitotic agent by CombinatoRx

April 2, 2004

Congress presentations report PD-0332991's biochemical, pharmacological and pharmacokinetic profile

April 1, 2004

Pladienolide D derivative, E-7107, shows good antitumor activity in xenografts

April 1, 2004

Bayer claims diagnostics and therapeutics for GPR19-associated diseases

April 1, 2004

Enrollment opens in phase III trial of STR in multiple myeloma

April 1, 2004

YM BioSciences to commence pivotal tesmilifene trial in coming weeks

April 1, 2004

NAD-299, RS-23597 active in prostate cancer cells

April 1, 2004

Atrasentan delays disease progression in metastatic prostate cancer

April 1, 2004

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...